Prosecution Insights
Last updated: July 17, 2026
Application No. 18/286,097

Early Pregnancy Testing Pen Casing and Early Pregnancy Testing Pen

Non-Final OA §101§102§103
Filed
Oct 07, 2024
Priority
Apr 08, 2021 — CN 202120713738.8 +1 more
Examiner
LIU, CHU CHUAN
Art Unit
Tech Center
Assignee
Abbott Diagnostics (Shanghai) Co. Ltd.
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
1y 7m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
548 granted / 770 resolved
+11.2% vs TC avg
Moderate +14% lift
Without
With
+13.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
36 currently pending
Career history
803
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
65.2%
+25.2% vs TC avg
§102
4.7%
-35.3% vs TC avg
§112
4.4%
-35.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 770 resolved cases

Office Action

§101 §102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claims 1-9 are objected to because of the following informalities: In regard to claims 1-9, the claims contain reference numbers. It is suggested that the numbers should be deleted. Appropriate correction is required. Claim 5-9 are objected to under 37 CFR 1.75(c) as being in improper form because a multiple dependent claim 4. See MPEP § 608.01(n). Accordingly, the claims 5-9 not been further treated on the merits. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Section 33(a) of the America Invents Act reads as follows: Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism. Claims 1-9 are rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). Claims that depend directly or indirectly from claim 1 is/are also rejected due to said dependency. In regard to claim 1, claim 1 recites “the handheld section (22) is used for being held by a user”. The phrase should be read as “the handheld section (22) is configured to be held by a user” to avoid improperly defining the apparatus in relation to a living being. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Laverack et al. (USPGPUB 2020/0114348 – applicant cited). In regard to claim 1, Laverack discloses an early pregnancy testing pen casing (Figs. 1-10 and associated descriptions), comprising a first casing body (1) (element 33, Figs. 5-6 and associated descriptions) and a second casing body (2) (elements 9/13 and 34, Figs. 1-6 and associated descriptions), wherein the second casing body (2) is divided into a functional section (21) (element 34, Figs. 5-6 and associated descriptions) and a handheld section (22) arranged in a length direction of the second casing body (2) (element 9/13, Figs. 1-10 and associated descriptions); the first casing body (1) is opposite to the functional section (21) so that an accommodating space for accommodating a test strip (3) is formed between the first casing body (1) and the functional section (21) (space associated with elements 29 and 55 for holding test strip 7 and absorbent wick 55, Figs. 2-4, 7A, 9E, and 10 and associated descriptions); the accommodating space has an opening for a water absorption piece (4) located in the accommodating space to extend out of the early pregnancy testing pen casing through the opening (absorbent wick 55 extended through the opening formed between elements 33d and 34d, Figs. 3-4 and 7-8 and associated descriptions); the handheld section (22) is used for being held by a user (elements 9-13, Figs. 1-6 and associated descriptions); and the handheld section (22) does not overlap the first casing body (1) (Figs. 2-3 and 6-10 and associated descriptions). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 2-4 are rejected under 35 U.S.C. 103 as being unpatentable over Laverack. In regard to claims 2-4, Laverack discloses the second casing body (2) has a casing plate (220) (element 9, Figs. 1-10 and associated descriptions), and a plate surface of the casing plate (220) located at the handheld section (22) (surfaces 16 and/or 18, Figs. 3-8 and associated descriptions) is provided with gripping elements arranged in patterns (elements 15 and/or 19, Figs. 3-8 and associated descriptions; [0126]), wherein the ridges 15 and gripping elements 19 could be exchanged with one or more concave features such as indentations or the like ([0126]) but does not specifically disclose the plate surface of the casing plate (220) located at the handheld section (22) is provided with at least one through hole (221) running through up and down; there are a plurality of through holes (221) that are arranged in the length direction of the second casing body (2); the through hole (221) extends in a width direction of the second casing body (2). One of ordinary skill in the art would have recognized that through holes provides similar gripping functions and reduce the weight and/or material of the handle. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to substitute the gripping configurations with through holes in similar patterns to yield predictable results, since through holes are alternative equivalent gripping configurations. The rationale would have been the simple substitution of one known, equivalent element for another to obtain predictable results (obvious to substitute elements, devices, etc.), KSR, 550, U.S. at 417. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHU CHUAN LIU whose telephone number is (571)270-5507. The examiner can normally be reached M-Th (6am-6pm). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHU CHUAN LIU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Oct 07, 2024
Application Filed
Jun 02, 2025
Response after Non-Final Action
Jun 22, 2026
Non-Final Rejection mailed — §101, §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661036
DETECTION DEVICE
3y 6m to grant Granted Jun 23, 2026
Patent 12661037
OPTICAL MODULE
2y 9m to grant Granted Jun 23, 2026
Patent 12653461
WEARABLE DEVICE AND METHODS OF MANUFACTURING
2y 7m to grant Granted Jun 16, 2026
Patent 12648751
ELECTRONIC STETHOSCOPE WITH A SONOGRAM
2y 8m to grant Granted Jun 09, 2026
Patent 12642463
SYSTEM FOR MONITORING FETAL STATUS DURING CHILDBIRTH
2y 11m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
85%
With Interview (+13.9%)
3y 4m (~1y 7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 770 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month